MedTrace Logo

Home Spirometry in Primary Care: an Implementation Study

NCT05162157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2023-02-23

No results posted yet for this study

Summary

Rationale: Spirometry is essential in the diagnosis of airway disease and can be useful in monitoring patients. Despite the essential role, spirometry remains largely underused in primary care. Due to Coronavirus disease (COVID-19), the use of office spirometry is contraindicated in many countries. Furthermore, spirometric devices are costly and personnel requires special training. Referral for spirometry increases the cost for patients and lowers the feasibility. Part of the reason for underdiagnosis of airway disease are the specific situations (such as exercise-induced asthma) in which spirometry in office setting might not reveal abnormalities. In recent years, handheld spirometry linked to phones/apps has been developed for study purposes and remote monitoring.

Objective: To study the feasibility, quality and added value of at-home spirometry for the diagnosis and monitoring of asthma and Chronic Obstructive Pulmonary Disease (COPD) in primary care.

Conditions

  • COPD Asthma

Interventions

DEVICE

NuvoAir platform

Nuvoair platform, consisting of a bluetooth spirometer, smartphone application and clinical portal

Sponsors & Collaborators

  • General Practitioners Research Institute

    lead NETWORK

Principal Investigators

  • Janwillem Kocks · General Practitioners Research Institute

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2022-12-28
Completion
2022-12-28

Countries

  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162157 on ClinicalTrials.gov